CardioSignal by Precordior Revenue and Competitors
Estimated Revenue & Valuation
- CardioSignal by Precordior's estimated annual revenue is currently $11.3M per year.
- CardioSignal by Precordior's estimated revenue per employee is $304,432
- CardioSignal by Precordior's total funding is $20M.
Employee Data
- CardioSignal by Precordior has 37 Employees.
- CardioSignal by Precordior grew their employee count by -5% last year.
CardioSignal by Precordior's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | President & CMO, US operations | Reveal Email/Phone |
4 | CTO | Reveal Email/Phone |
5 | Director, Sales and Business Intelligence | Reveal Email/Phone |
6 | Research & Quality Director | Reveal Email/Phone |
7 | Data Scientist | Reveal Email/Phone |
8 | Study and product specialist | Reveal Email/Phone |
CardioSignal by Precordior Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $32M | 84 | 9% | $67.7M | N/A |
#2 | $11.3M | 37 | -5% | $20.2M | N/A |
What Is CardioSignal by Precordior?
CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well.\n\nCardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. \n\nOur purpose\nWe are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. \n\nEarly identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.
keywords:N/A
$20M
Total Funding
37
Number of Employees
$11.3M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Turku
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.4M | 38 | 27% | N/A |
#2 | $7.6M | 54 | 26% | N/A |
#3 | $7.4M | 57 | -2% | N/A |
#4 | $10.1M | 65 | 5% | N/A |
#5 | $13.5M | 67 | 18% | $14M |